We have previously reported that IDO expression in tumor cells and the serum concentration of kynurenine in patients with diffuse large B-cell lymphoma [15–17], or with acute myeloid leukemia [18, 19] are useful prognostic factors. The gene discussed is IDO1; the disease is neoplasm.